Extracorporeal photopheresis in Sezary syndrome

被引：25
|
作者：
RussellJones, R
FraserAndrews, E
Spittle, M
Whittaker, S
机构：
来源：
LANCET | 1997年 / 350卷 / 9081期
关键词：
D O I：
10.1016/S0140-6736(05)62067-3
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：886 / 886
页数：1
相关论文
共 50 条
  • [21] Combination treatment with extracorporeal photopheresis, interferon alfa and interleukin-2 in a patient with the Sezary syndrome
    Fritz, TM
    Kleinhans, M
    Nestle, FO
    Burg, G
    Dummer, R
    BRITISH JOURNAL OF DERMATOLOGY, 1999, 140 (06) : 1144 - 1147
  • [22] Combination therapy with extracorporeal photopheresis, interferon-α, PUVA and topical corticosteroids in the management of Sezary syndrome
    Booken, Nina
    Weiss, Christel
    Utikal, Jochen
    Felcht, Moritz
    Goerdt, Sergij
    Klemke, Claus-Detlev
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2010, 8 (06): : 428 - 438
  • [23] Effect of insulin-dependent diabetes mellitus on response to extracorporeal photopheresis patients with Sezary syndrome
    Bouwhuis, SA
    el-Azhary, RA
    Gibson, LE
    McEvoy, MT
    Pittelkow, MR
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 47 (01) : 63 - 67
  • [24] Extracorporeal photopheresis and adjuvant aerosolized granulocyte-macrophage colony-stimulating factor for Sezary syndrome
    Bouwhuis, SA
    Markovic, SN
    McEvoy, MT
    Pittelkow, MR
    MAYO CLINIC PROCEEDINGS, 2002, 77 (02) : 197 - 200
  • [25] Enhancement of antibody-dependent cellular cytotoxicity is associated with treatment response to extracorporeal photopheresis in Sezary syndrome
    Iselin, Christoph
    Chang, Yun-Tsan
    Schlaepfer-Eberle, Tanja
    Fassnacht, Christina
    Dimitriou, Florentia
    Naegeli, Mirjam
    Pascolo, Steve
    Hoetzenecker, Wolfram
    Bobrowicz, Malgorzata
    Guenova, Emmanuella
    EUROPEAN JOURNAL OF CANCER, 2021, 156 : S7 - S7
  • [26] The Efficacy of Vorinostat in Combination With Interferon Alpha and Extracorporeal Photopheresis in Late Stage Mycosis Fungoides and Sezary Syndrome
    Sanli, Hatice
    Akay, Bengu Nisa
    Anadolu, Rana
    Ozcan, Muhit
    Saral, Secil
    Akyol, Aynur
    JOURNAL OF DRUGS IN DERMATOLOGY, 2011, 10 (04) : 403 - 408
  • [27] Enhancement of antibody-dependent cellular cytotoxicity is associated with treatment response to extracorporeal photopheresis in Sezary syndrome
    Iselin, Christoph
    Chang, Yun-Tsan
    Schlaepfer, Tanja
    Fassnacht, Christina
    Dimitriou, Florentia
    Nageli, Mirjam
    Pascolo, Steve
    Hoetzenecker, Wolfram
    Bobrowicz, Malgorzata
    Guenova, Emmanuella
    ONCOIMMUNOLOGY, 2021, 10 (01):
  • [28] Enhancement of antibody-dependent cellular cytotoxicity is associated with treatment response to extracorporeal photopheresis in Sezary syndrome
    Iselin, C.
    Chang, Y.
    Schlaepfer, T.
    Fassnacht, C.
    Dimitriou, F.
    Naegeli, M.
    Pascolo, S.
    Hoetzenecker, W.
    Bobrowicz, M.
    Guenova, E.
    EXPERIMENTAL DERMATOLOGY, 2021, 30 (03) : E84 - E84
  • [29] Sezary Syndrome with Nodal CD30-positive Manifestation Treated with Brentuximab Vedotin and Extracorporeal Photopheresis
    Behle, Valeria
    Von Braunmuehl, Tanja
    Sayehli, Cyrus
    Gesierich, Anja
    Goebeler, Matthias
    Geissinger, Eva
    Wobser, Marion
    ACTA DERMATO-VENEREOLOGICA, 2017, 97 (08) : 973 - 975
  • [30] A prospective study on the evolution of the T-cell repertoire in patients with Sezary syndrome treated by extracorporeal photopheresis
    Ingen-Housz-Oro, S
    Bussel, A
    Flageul, B
    Michel, L
    Dubertret, L
    Kourilsky, P
    Gachelin, G
    Bachelez, H
    Musette, P
    BLOOD, 2002, 100 (06) : 2168 - 2174
12345